Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
19,667,509
-
Total 13F shares
-
22,040,895
-
Share change
-
-642,743
-
Total reported value
-
$2,466,046,768
-
Put/Call ratio
-
464%
-
Price per share
-
$111.85
-
Number of holders
-
250
-
Value change
-
-$51,378,592
-
Number of buys
-
114
-
Number of sells
-
137
Institutional Holders of LIGAND PHARMACEUTICALS INC - Common Stock (LGND) as of Q2 2020
As of 30 Jun 2020,
LIGAND PHARMACEUTICALS INC - Common Stock (LGND) was held by
250 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,040,895 shares.
The largest 10 holders included
BlackRock Inc., JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, WASATCH ADVISORS INC, CARDINAL CAPITAL MANAGEMENT LLC /CT, MACQUARIE GROUP LTD, Conestoga Capital Advisors, LLC, and VILLERE ST DENIS J & CO LLC.
This page lists
251
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.